7 presentations were found matching your search word IS-S3 .

International Session (Symposium)3 (JSH, JSGE, JSGS)

November 5, 9:30–12:00, Room 2 (Kobe International Exhibition Hall No.2 Building Hall (South))

Advances in the treatment of the liver cancer: The state-of-the-art researches to provide the precision medicine and improve the prognosis

Time Slot for Each Speaker: (Time slots vary depending on presentations. Please prepare your presentation as below.)
  IS-S3-Keynote Lecture，IS-S3-Special Remarks : 20 min. for oral presentation
  Other Presentations: 15 min. for oral presentation, 7 min. for Q&A
Discussion: Not to be held
Introductory Meeting: Not to be held
  • Chairperson:
    Masatoshi KudoDepartment of Gastroenterology and Hepatology, Kindai University Faculty of Medicine
  • Chairperson:
    Etsuro HatanoDivision of Hepato-Biliary-Pancreatic Surgery and Transplantation, Department of Surgery, Graduate School of Medicine, Kyoto University
  • Discussant:
    Kaoru TsuchiyaDepartment of Gastroenterology and Hepatology, Musashino Red Cross Hospital
  • Discussant:
    Sadahisa OgasawaraDepartment of Gastroenterology, Graduate School of Medicine, Chiba University

IS-S3-Keynote Lecture
The state-of-art Lecture on the Treatment of Liver Cancer

Masatoshi Kudo Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine

IS-S3-1_H
The effectiveness of the locoregional treatment using hepatic arterial infusion chemotherapy for locally progressed hepatocellular carcinoma

Hideki Iwamoto Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine,Iwamoto Internal Medicine Clinic

IS-S3-2_G
The impact of molecular targeted therapies and the multidisciplinary management for survival of patients with advanced hepatocellular carcinoma

Tomokazu Kawaoka Department of Gastroenterology and Metabolism, Hiroshima University Hospital

IS-S3-3_H
Serum MYCN as a predictive biomarker of prognosis and therapeutic response in the prevention of hepatocellular carcinoma

Xian-Yang Qin Liver Cancer Prevention Research Unit, RIKEN Cluster for Pioneering Research

IS-S3-4_H
Exploring tumor microenvironment in patients with advanced hepatocellular carcinoma using needle biopsy samples Young Award

Hiroaki Kanzaki Department of Gastroenterology, Graduate School of Medicine, Chiba University

IS-S3-5_H
A new therapeutic strategy using cell-free DNA that predicts drug resistance of atezolizumab+bevacizumab for the treatment of advanced hepatocellular carcinoma.

Asahiro Morishita Kagawa University, Department of Gastroenterology and Neurology

IS-S3-Special Remarks

Norihiro Kokudo National Center for Global Health and Medicine

Page Top

Page Top